This inventor holds 3 USPTO granted patents, plus 2 CIPO patents. Top assignees: Taisho Pharmaceutical Co., Ltd., Sumitomo Pharmaceuticals Company Limited, Wisconsin Alumni Research Foundation. Active years: 1994-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ageo, JP (1994)
- Tokyo, JP (1998 - 1999)
Company Filing History:


Years Active: 1994-1999
Title: Shigeru Itai: Innovator in Pharmaceutical Composition
Introduction
Shigeru Itai is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of taste masking compositions for oral administration. With a total of 3 patents to his name, Itai's work has had a meaningful impact on the industry.
Latest Patents
Among his latest patents, Shigeru Itai has developed a taste masking pharmaceutical composition for oral administration. This innovation aims to improve the palatability of medications, making them easier for patients to consume. Additionally, he has patented a taste masking pharmaceutical composition, further enhancing the effectiveness of his formulations.
Career Highlights
Throughout his career, Shigeru Itai has worked with prominent companies in the pharmaceutical sector. He has been associated with Taisho Pharmaceutical Co., Ltd. and Sumitomo Pharmaceuticals Company Limited. His experience in these organizations has allowed him to refine his expertise and contribute to various innovative projects.
Collaborations
Shigeru Itai has collaborated with several talented individuals in his field. Notable coworkers include Kuniaki Ishii and Hidefumi Hayashi, who have worked alongside him on various projects, contributing to the advancement of pharmaceutical innovations.
Conclusion
Shigeru Itai is a distinguished inventor whose work in taste masking pharmaceutical compositions has made a significant impact in the field. His contributions continue to influence the way medications are formulated and administered, enhancing patient experiences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile